The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer
Recruiting
N/A
Interventional Study
Thyroid Nodule
Thyroid Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 100
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- University Health Network, Toronto · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to test radiofrequency ablation (RFA) in thyroid cancers ≤2 cm in diameter. The main question it aims to answer is:
• What is the feasibility of RFA use for low-risk thyroid cancers (≤2 cm)?
Participants will undergo a set of pre-procedural scans of the target thyroid nodule and undergo the RFA procedure/intervention. Then, participants will partake in three fo…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1\. Patients with:
* Nodule less than or equal to 2cm in size
a. Specifically: Bethesda 5/6
* Their age is ≥18 years and ≤100 years
* Able to provide written consent
* Able to attend required follow-ups as per the protocol
Exclusion Criteria:
* Patients \<18 years old
* Pr…
Contacts